fdfee843e49058b3cf8ae90e5e06b591 269681.pdf 924e5b8c52f68f3d6b9db4a2b2ea183733d670fa 269681.pdf 42fce570b722bbf92b3ddbb3ed43a1e6d18928c027a09632505ee96451259e9e 269681.pdf Title: Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial Subject: Dermatology and Therapy, https://doi.org/10.1007/s13555-021-00554-4 Keywords: Netakimab,Psoriasis,Interleukin-17 inhibitors Author: Luís Puig Creator: Springer Producer: Acrobat Distiller 10.1.8 (Windows) CreationDate: Sun May 30 11:04:53 2021 CEST ModDate: Sat Jul 24 05:54:45 2021 CEST Tagged: no UserProperties: no Suspects: no Form: AcroForm JavaScript: no Pages: 14 Encrypted: no Page size: 595.276 x 790.866 pts Page rot: 0 File size: 647389 bytes Optimized: yes PDF version: 1.6 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- RQAPHG+AdvSTONE-R Type 1C MacRoman yes yes no 285 0 RAOIPJ+AdvPSSPS-AS Type 1C Custom yes yes yes 302 0 FKERCD+AdvPTimes Type 1C WinAnsi yes yes no 308 0 JYIHLQ+AdvSTONE-SB Type 1C MacRoman yes yes no 287 0 LYVYFP+AdvPSSym Type 1C Custom yes yes no 288 0 RXTCVT+AdvSTONESF-R Type 1C WinAnsi yes yes no 283 0 NUMUUF+AdvSTONE-SBI Type 1C WinAnsi yes yes no 284 0 NGDDIS+AdvTir_symb Type 1C WinAnsi yes yes no 295 0 GJPKSF+AdvSTONE-I Type 1C WinAnsi yes yes no 296 0 MFDMYE+AdvPSMP4 Type 1C WinAnsi yes yes no 297 0 TXPFQI+AdvP4C4E74 Type 1C Custom yes yes no 303 0 IUEIAL+AdvSTONESF-B Type 1C WinAnsi yes yes no 104 0 UKAEQQ+AdvOT6cddfb43.B Type 1C Custom yes yes yes 134 0 NTFEVO+AdvOT2015df00 Type 1C Custom yes yes yes 135 0 ROVWHI+AdvOT1a356080.I Type 1C Custom yes yes yes 121 0 FVDMTU+AdvOT8f27407c.BI Type 1C Custom yes yes yes 143 0 FWDTFT+AdvPSMPi6 Type 1C Custom yes yes yes 147 0 XBGBTI+AdvPTimesB Type 1C WinAnsi yes yes no 156 0 Jhove (Rel. 1.22.1, 2019-04-17) Date: 2023-05-27 03:15:46 CEST RepresentationInformation: 269681.pdf ReportingModule: PDF-hul, Rel. 1.12.1 (2019-04-17) LastModified: 2023-03-31 12:04:41 CEST Size: 647389 Format: PDF Version: 1.6 Status: Well-Formed and valid SignatureMatches: PDF-hul MIMEtype: application/pdf Profile: Linearized PDF PDFMetadata: Objects: 374 FreeObjects: 1 IncrementalUpdates: 1 DocumentCatalog: PageLayout: SinglePage PageMode: UseOutlines Language: EN Outlines: Item: Title: Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@87f383f Children: Item: Title: Abstract Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4eb7f003 Children: Item: Title: Introduction Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@eafc191 Item: Title: Methods Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@612fc6eb Item: Title: Results Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1060b431 Item: Title: Conclusion Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@612679d6 Item: Title: Clinical Trial Registration Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@11758f2a Item: Title: Digital Features Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@e720b71 Item: Title: Introduction Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1b26f7b2 Item: Title: Methods Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@491cc5c9 Children: Item: Title: Study Outcomes Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@74ad1f1f Item: Title: Sample Size Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6a1aab78 Item: Title: Statistical Analysis Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@462d5aee Item: Title: Results Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@69b0fd6f Children: Item: Title: Efficacy Analysis Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@757942a1 Item: Title: Safety Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4a87761d Item: Title: Safety Results of NTK Q2W/Q4W and NTK Q4W Groups Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@66d1af89 Item: Title: Safety Results of the Placebo/NTK Q4W Group Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@8646db9 Item: Title: Immunogenicity Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@37374a5e Item: Title: Discussion Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4671e53b Item: Title: Conclusion Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@2db7a79b Item: Title: Acknowledgements Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6950e31 Item: Title: References Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@b7dd107 Info: Title: Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial Author: Luís Puig Subject: Dermatology and Therapy, https://doi.org/10.1007/s13555-021-00554-4 Keywords: Netakimab,Psoriasis,Interleukin-17 inhibitors Creator: Springer Producer: Acrobat Distiller 10.1.8 (Windows) CreationDate: Sun May 30 11:34:53 CEST 2021 ModDate: Sat Jul 24 06:24:45 CEST 2021 ID: 0x78ed79a4d10ab1b20018afb6f1533496, 0x48cb7fbc5ebe8744b0aebb1a5eb56f6b Filters: FilterPipeline: FlateDecode FilterPipeline: DCTDecode Images: Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1775 ImageHeight: 1397 ColorSpace: black is zero BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1137 ImageHeight: 2580 BitsPerSample: 8 BitsPerSampleUnit: integer Intent: Perceptual Fonts: Type1: Font: BaseFont: LYVYFP+AdvPSSym FontSubset: true FirstChar: 2 LastChar: 4 FontDescriptor: FontName: LYVYFP+AdvPSSym Flags: Serif, Symbolic FontBBox: -177, -291, 1083, 1010 FontFile3: true EncodingDictionary: Differences: true Font: BaseFont: UKAEQQ+AdvOT6cddfb43.B FontSubset: true FirstChar: 37 LastChar: 135 FontDescriptor: FontName: UKAEQQ+AdvOT6cddfb43.B Flags: Serif, Symbolic FontBBox: -187, -270, 1041, 843 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: NGDDIS+AdvTir_symb FontSubset: true FirstChar: 32 LastChar: 177 FontDescriptor: FontName: NGDDIS+AdvTir_symb Flags: Serif, Nonsymbolic FontBBox: -166, -208, 1000, 729 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: NTFEVO+AdvOT2015df00 FontSubset: true FirstChar: 37 LastChar: 150 FontDescriptor: FontName: NTFEVO+AdvOT2015df00 Flags: Serif, Symbolic FontBBox: -177, -270, 1031, 833 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: GJPKSF+AdvSTONE-I FontSubset: true FirstChar: 32 LastChar: 177 FontDescriptor: FontName: GJPKSF+AdvSTONE-I Flags: Serif, Nonsymbolic FontBBox: -208, -250, 1291, 760 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: IUEIAL+AdvSTONESF-B FontSubset: true FirstChar: 32 LastChar: 177 FontDescriptor: FontName: IUEIAL+AdvSTONESF-B Flags: Nonsymbolic FontBBox: -156, -239, 1531, 781 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: MFDMYE+AdvPSMP4 FontSubset: true FirstChar: 32 LastChar: 117 FontDescriptor: FontName: MFDMYE+AdvPSMP4 Flags: Serif, Nonsymbolic FontBBox: -208, -322, 958, 895 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: RAOIPJ+AdvPSSPS-AS FontSubset: true FirstChar: 38 LastChar: 40 FontDescriptor: FontName: RAOIPJ+AdvPSSPS-AS Flags: Symbolic FontBBox: 0, -250, 1052, 947 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: TXPFQI+AdvP4C4E74 FontSubset: true FirstChar: 2 LastChar: 4 FontDescriptor: FontName: TXPFQI+AdvP4C4E74 Flags: Symbolic FontBBox: -20, -958, 1114, 770 FontFile3: true EncodingDictionary: Differences: true Font: BaseFont: FVDMTU+AdvOT8f27407c.BI FontSubset: true FirstChar: 78 LastChar: 112 FontDescriptor: FontName: FVDMTU+AdvOT8f27407c.BI Flags: Symbolic FontBBox: -218, -312, 1062, 812 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FWDTFT+AdvPSMPi6 FontSubset: true FirstChar: 98 LastChar: 100 FontDescriptor: FontName: FWDTFT+AdvPSMPi6 Flags: Serif, Symbolic FontBBox: 0, -177, 989, 739 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FKERCD+AdvPTimes FontSubset: true FirstChar: 32 LastChar: 254 FontDescriptor: FontName: FKERCD+AdvPTimes Flags: Serif, Nonsymbolic FontBBox: -166, -208, 1000, 729 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: ROVWHI+AdvOT1a356080.I FontSubset: true FirstChar: 50 LastChar: 117 FontDescriptor: FontName: ROVWHI+AdvOT1a356080.I Flags: Symbolic FontBBox: -208, -291, 1083, 843 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: RXTCVT+AdvSTONESF-R FontSubset: true FirstChar: 32 LastChar: 177 FontDescriptor: FontName: RXTCVT+AdvSTONESF-R Flags: Nonsymbolic FontBBox: -177, -239, 1291, 760 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: NUMUUF+AdvSTONE-SBI FontSubset: true FirstChar: 32 LastChar: 254 FontDescriptor: FontName: NUMUUF+AdvSTONE-SBI Flags: Serif, Nonsymbolic FontBBox: -197, -250, 1333, 760 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: XBGBTI+AdvPTimesB FontSubset: true FirstChar: 32 LastChar: 177 FontDescriptor: FontName: XBGBTI+AdvPTimesB Flags: Serif, Nonsymbolic FontBBox: -166, -208, 1000, 781 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: RQAPHG+AdvSTONE-R FontSubset: true FirstChar: 32 LastChar: 255 FontDescriptor: FontName: RQAPHG+AdvSTONE-R Flags: Serif, Nonsymbolic FontBBox: -197, -239, 1270, 770 FontFile3: true Encoding: MacRomanEncoding Font: BaseFont: JYIHLQ+AdvSTONE-SB FontSubset: true FirstChar: 32 LastChar: 255 FontDescriptor: FontName: JYIHLQ+AdvSTONE-SB Flags: Serif, Nonsymbolic FontBBox: -187, -250, 1312, 770 FontFile3: true Encoding: MacRomanEncoding XMP: 2021-05-30T14:34:53+05:30 Springer 2021-07-24T09:24:45+05:30 2021-07-24T09:24:45+05:30 Acrobat Distiller 10.1.8 (Windows) Netakimab,Psoriasis,Interleukin-17 inhibitors application/pdf https://doi.org/10.1007/s13555-021-00554-4 Springer Healthcare Dermatology and Therapy, https://doi.org/10.1007/s13555-021-00554-4 Netakimab Psoriasis Interleukin-17 inhibitors Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial Luís Puig Andrey L. Bakulev Muza M. Kokhan Alexey V. Samtsov Vladislav R. Khairutdinov Maria A. Morozova Nikita A. Zolkin Ivan V. Kuryshev Alexey N. Petrov Antonina V. Artemeva Arina V. Zinkina-Orikhan 10.1007/s13555-021-00554-4 2010-04-23 true springer.com springerlink.com https://doi.org/10.1007/s13555-021-00554-4 10.1007/s13555-021-00554-4 2190-9172 11 4 1319 1332 journal Dermatology and Therapy The Author(s) 2010-04-23 true 10.1007/s13555-021-00554-4 noindex springer.com springerlink.com VoR uuid:352c82b3-e5ab-4713-a962-697035f6c308 uuid:f6c8db4f-7fbe-496a-bb53-b479fd5beec4 default 1 converted uuid:5419c05a-6cbb-4d20-baba-b81d9274a172 converted to PDF/A-2b pdfToolbox 2021-07-24T09:23:33+05:30 converted uuid:efc7c20b-c878-419d-86d3-e3660803c322 converted to PDF/A-2b pdfToolbox 2021-07-24T09:24:45+05:30 2 B Maria A. Morozova http://orcid.org/0000-0001-7755-7526 http://ns.adobe.com/pdfx/1.3/ pdfx Adobe Document Info PDF eXtension Schema external Mirrors crossmark:MajorVersionDate CrossmarkMajorVersionDate Text external Mirrors crossmark:CrossmarkDomainExclusive CrossmarkDomainExclusive Text internal Mirrors crossmark:DOI doi Text external Mirrors crossmark:CrosMarkDomains CrossMarkDomains seq Text internal A name object indicating whether the document has been modified to include trapping information robots Text internal ID of PDF/X standard GTS_PDFXVersion Text internal Conformance level of PDF/X standard GTS_PDFXConformance Text internal Company creating the PDF Company Text internal Date when document was last modified SourceModified Text http://crossref.org/crossmark/1.0/ crossmark Crossmark Schema internal Usual same as prism:doi DOI Text external The date when a publication was publishe. MajorVersionDate Text internal CrossmarkDomainExclusive CrossmarkDomainExclusive Text internal CrossMarkDomains CrossMarkDomains seq Text http://prismstandard.org/namespaces/basic/2.0/ prism Prism Schema external This element provides the url for an article or unit of content. The attribute platform is optionally allowed for situations in which multiple URLs must be specified. PRISM recommends that a subset of the PCV platform values, namely “mobile” and “web”, be used in conjunction with this element. NOTE: PRISM recommends against the use of the #other value allowed in the PRISM Platform controlled vocabulary. In lieu of using #other please reach out to the PRISM group at prism-wg@yahoogroups.com to request addition of your term to the Platform Controlled Vocabulary. url URI external The Digital Object Identifier for the article. The DOI may also be used as the dc:identifier. If used as a dc:identifier, the URI form should be captured, and the bare identifier should also be captured using prism:doi. If an alternate unique identifier is used as the required dc:identifier, then the DOI should be specified as a bare identifier within prism:doi only. If the URL associated with a DOI is to be specified, then prism:url may be used in conjunction with prism:doi in order to provide the service endpoint (i.e. the URL). doi Text external ISSN for an electronic version of the issue in which the resource occurs. Permits publishers to include a second ISSN, identifying an electronic version of the issue in which the resource occurs (therefore e(lectronic)Issn. If used, prism:eIssn MUST contain the ISSN of the electronic version. issn Text internal Volume number volume Text internal Issue number number Text internal Starting page startingPage Text internal Ending page endingPage Text external The aggregation type specifies the unit of aggregation for a content collection. Comment PRISM recommends that the PRISM Aggregation Type Controlled Vocabulary be used to provide values for this element. Note: PRISM recommends against the use of the #other value currently allowed in this controlled vocabulary. In lieu of using #other please reach out to the PRISM group at info@prismstandard.org to request addition of your term to the Aggregation Type Controlled Vocabulary. aggregationType Text external Title of the magazine, or other publication, in which a resource was/will be published. Typically this will be used to provide the name of the magazine an article appeared in as metadata for the article, along with information such as the article title, the publisher, volume, number, and cover date. Note: Publication name can be used to differentiate between a print magazine and the online version if the names are different such as “magazine” and “magazine.com.” publicationName Text external Copyright copyright Text http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema internal A name object indicating whether the document has been modified to include trapping information Trapped Text http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI internal The common identifier for all versions and renditions of a document. DocumentID URI internal The common identifier for all versions and renditions of a document. OriginalDocumentID URI internal A reference to the original document from which this one is derived. It is a minimal reference; missing components can be assumed to be unchanged. For example, a new version might only need to specify the instance ID and version number of the previous version, or a rendition might only need to specify the instance ID and rendition class of the original. DerivedFrom ResourceRef Identifies a portion of a document. This can be a position at which the document has been changed since the most recent event history (stEvt:changed). For a resource within an xmpMM:Ingredients list, the ResourceRef uses this type to identify both the portion of the containing document that refers to the resource, and the portion of the referenced resource that is referenced. http://ns.adobe.com/xap/1.0/sType/Part# stPart Part http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text Springer Nature ORCID Schema http://springernature.com/ns/xmpExtensions/2.0/ sn authorInfo Bag AuthorInformation external Author information: contains the name of each author and his/her ORCiD (ORCiD: Open Researcher and Contributor ID). An ORCiD is a persistent identifier (a non-proprietary alphanumeric code) to uniquely identify scientific and other academic authors. AuthorInformation http://springernature.com/ns/xmpExtensions/2.0/authorInfo/ author Specifies the types of author information: name and ORCID of an author. name Text Gives the name of an author. orcid URI Gives the ORCID of an author. http://ns.adobe.com/xap/1.0/t/pg/ xmpTPg XMP Paged-Text internal XMP08 Spec: An ordered array of plate names that are needed to print the document (including any in contained documents). PlateNames Seq Text http://www.niso.org/schemas/jav/1.0/ jav NISO external Values for Journal Article Version are one of the following: AO = Author’s Original SMUR = Submitted Manuscript Under Review AM = Accepted Manuscript P = Proof VoR = Version of Record CVoR = Corrected Version of Record EVoR = Enhanced Version of Record journal_article_version Closed Choice of Text Pages: Page: Label: 1319 Sequence: 1 Annotations: Annotation: Subtype: Link Rect: 137, 552, 145, 563 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 239, 309, 269, 318 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 44, 300, 56, 308 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 44, 300, 56, 308 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 56, 300, 203, 308 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 495, 731, 524, 760 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 56, 730, 207, 738 Flags: Print AppearanceDictionary: true Thumb: true Page: Label: 1320 Sequence: 2 Annotations: Annotation: Subtype: Link Rect: 180, 179, 293, 189 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 70, 167, 173, 176 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 433, 591, 438, 601 Flags: Print AppearanceDictionary: true Destination: 85 Annotation: Subtype: Link Rect: 483, 479, 488, 489 Flags: Print AppearanceDictionary: true Destination: 85 Annotation: Subtype: Link Rect: 494, 479, 500, 489 Flags: Print AppearanceDictionary: true Destination: 85 Thumb: true Page: Label: 1321 Sequence: 3 Annotations: Annotation: Subtype: Link Rect: 384, 213, 389, 223 Flags: Print AppearanceDictionary: true Destination: 92 Thumb: true Page: Label: 1322 Sequence: 4 Annotations: Annotation: Subtype: Link Rect: 95, 512, 101, 522 Flags: Print AppearanceDictionary: true Destination: 92 Annotation: Subtype: Link Rect: 420, 233, 426, 243 Flags: Print AppearanceDictionary: true Destination: 27 Thumb: true Page: Label: 1323 Sequence: 5 Annotations: Annotation: Subtype: Link Rect: 191, 278, 197, 288 Flags: Print AppearanceDictionary: true Destination: 34 Thumb: true Page: Label: 1324 Sequence: 6 Annotations: Annotation: Subtype: Link Rect: 93, 234, 99, 243 Flags: Print AppearanceDictionary: true Destination: 47 Annotation: Subtype: Link Rect: 469, 146, 475, 156 Flags: Print AppearanceDictionary: true Destination: 47 Thumb: true Page: Label: 1325 Sequence: 7 Thumb: true Page: Label: 1326 Sequence: 8 Annotations: Annotation: Subtype: Link Rect: 93, 552, 99, 562 Flags: Print AppearanceDictionary: true Destination: 47 Thumb: true Page: Label: 1327 Sequence: 9 Annotations: Annotation: Subtype: Link Rect: 333, 529, 339, 539 Flags: Print AppearanceDictionary: true Destination: 65 Annotation: Subtype: Link Rect: 487, 166, 493, 176 Flags: Print AppearanceDictionary: true Destination: 92 Annotation: Subtype: Link Rect: 499, 166, 505, 176 Flags: Print AppearanceDictionary: true Destination: 92 Thumb: true Page: Label: 1328 Sequence: 10 Thumb: true Page: Label: 1329 Sequence: 11 Thumb: true Page: Label: 1330 Sequence: 12 Annotations: Annotation: Subtype: Link Rect: 185, 529, 190, 539 Flags: Print AppearanceDictionary: true Destination: 92 Annotation: Subtype: Link Rect: 281, 504, 287, 514 Flags: Print AppearanceDictionary: true Destination: 92 Annotation: Subtype: Link Rect: 163, 342, 168, 352 Flags: Print AppearanceDictionary: true Destination: 92 Thumb: true Page: Label: 1331 Sequence: 13 Annotations: Annotation: Subtype: Link Rect: 335, 283, 524, 293 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 301, 270, 335, 280 Flags: Print AppearanceDictionary: true Thumb: true Page: Label: 1332 Sequence: 14 Annotations: Annotation: Subtype: Link Rect: 140, 635, 293, 643 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 82, 625, 261, 633 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 425, 695, 538, 703 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 327, 685, 538, 693 Flags: Print AppearanceDictionary: true Annotation: Subtype: Link Rect: 327, 675, 423, 683 Flags: Print AppearanceDictionary: true Thumb: true Checksum: 65eede15 Type: CRC32 Checksum: fdfee843e49058b3cf8ae90e5e06b591 Type: MD5 Checksum: 924e5b8c52f68f3d6b9db4a2b2ea183733d670fa Type: SHA-1